Dropout in a longitudinal, cohort study of urologic disease in community men

BMC Medical Research Methodology

Volumn 6, Issue , 2006, Pages

  Gades, Naomi M ^a   Jacobson, Debra J ^a   McGree, Michaela E ^a   Lieber, Michael M ^a   Roberts, Rosebud O ^a   Girman, Cynthia J ^a,b   Jacobsen, Steven J ^c  

^a Mayo Clinic   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CAUCASIAN; COMMUNITY CARE; COMORBIDITY; CONTROLLED STUDY; FOLLOW UP; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEN'S HEALTH; PROSTATE HYPERTROPHY; QUESTIONNAIRE; SCREENING; SOCIOECONOMICS; STROKE; URINARY TRACT DISEASE; UROLOGIC EXAMINATION; AGE; COHORT ANALYSIS; COMPLICATION; DEMOGRAPHY; EPIDEMIOLOGY; HEALTH STATUS; MIDDLE AGED; PATIENT DROPOUTS; PATIENT SELECTION; PROSPECTIVE STUDY; PROSTATIC DISEASES; PSYCHOLOGY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RESEARCH SUBJECT; SOCIAL CLASS; STATISTICS AND NUMERICAL DATA; UNITED STATES; UROLOGIC DISEASES;

ADULT; AGE FACTORS; AGED; COHORT STUDIES; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; MINNESOTA; PATIENT DROPOUTS; PATIENT SELECTION; PROSPECTIVE STUDIES; PROSTATIC DISEASES; QUALITY OF LIFE; QUESTIONNAIRES; RESEARCH SUBJECTS; RESIDENCE CHARACTERISTICS; SOCIAL CLASS; UROLOGIC DISEASES;

EID: 33846641700     PISSN: None     EISSN: 14712288     Source Type: Journal    
DOI: 10.1186/1471-2288-6-58     Document Type: Article

References (27)

1. Szklo M, Nieto FJ: Quality assurance and control. In Epidemiology: Beyond the Basics Edited by: Brown M. Sudbury, MA, Jones and Bartlett Publishers, Inc.; 2004.
2. Lee AJ, Garraway WM, Simpson RJ, Fisher W, King D: The natural history of untreated lower urinary tract symptoms in middle-aged and elderly men over a period of five years. EurUrol 1998, 34:325-332.
3. McConnell JD, Roehrborn CG, Bautista OM, Andriole GL Jr., Dixon CM, Kusek JW, Lepor H, McVary KT, Nyberg LM Jr., Clarke HS, Crawford ED, Diokno A, Foley JP, Foster HE, Jacobs SC, Kaplan SA, Kreder KJ, Lieber MM, Lucia MS, Miller GJ, Menon M, Milam DF, Ramsdell JW, Schenkman NS, Slawin KM, Smith JA, Medical Therapy of Prostatic Symptoms Research G: The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med 2003, 349:2387-2398.
4. Wessells H, Roy J, Bannow J, Grayhack J, Matsumoto AM, Tenover L, Herlihy R, Fitch W, Labasky R, Auerbach S, Parra R, Rajfer J, Culbertson J, Lee M, Bach MA, Waldstreicher J: Incidence and severity of sexual adverse experiences in finasteride and placebo-treated men with benign prostatic hyperplasia. Urology 2003, 61:579-584.
5. Roehrborn CG, McConnell JD, Saltzman B, Bergner D, Gray T, Narayan P, Cook TJ, Johnson-Levonas AO, Quezada WA, Waldstreicher J: Storage (irritative) and voiding (obstructive) symptoms as predictors of benign prostatic hyperplasia progression and related outcomes. Eur Urol 2002, 42:1-6.
6. Roehrborn CG: Reporting of acute urinary retention in BPH treatment trials: importance of patient follow-up after discontinuation and case definitions. Urology 2002, 59:811-815.
7. Chute CG, Panser LA, Girman CJ, Oesterling JE, Guess HA, Jacobsen SJ, Lieber MM: The prevalence of prostatism: a population-based survey of urinary symptoms. J Urol 1993, 150:85-89.
8. Jacobsen SJ, Guess HA, Panser L, Girman CJ, Chute CG, Oesterling JE, Lieber MM: A population-based study of health care-seeking behavior for treatment of urinary symptoms: The Olmsted County Study of Urinary Symptoms and Health Status Among Men. Arch Fam Med 1993, 2:729-735.
9. Oesterling JE, Jacobsen SJ, Chute CG, Guess HA, Girman CJ, Panser LA, Lieber MM: Serum prostate-specific antigen in a community-based population of healthy men: Establishment of age-specific reference ranges. JAMA 1993, 270:860-864.
10. Melton LJ III: History of the Rochester Epidemiology Project. Mayo Clin Proc 1996, 71:266-274.
11. Barry MJ, Fowler FJJ, O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, The, Measurement, Committee, of, the, American, Urological, Association.: Correlation of the American Urological Association Symptom Index with self-administered versions of the Madsen-Iversen, Boyarsky and Maine Medical Assessment Program Symptom Indexes. J Urol 1992, 148:1558- 1563.
12. Cockett AT, Barry MJ, Holtgrewe HL, Sihelnick S, Williams R, McConnell J: Indications for treatment of benign prostatic hyperplasia. The American Urological Association Study. Cancer 1992, 70(1 Suppl):280-283.
13. AUA Practice Guidelines Committee. AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations. J Urol 2003, 170:530-547.
14. Epstein RS, Deverka PA, Chute CG, Panser L, Oesterling JE, Lieber MM, Schwartz S, Patrick D: Validation of a new quality of life questionnaire for benign prostatic hyperplasia. JClinEpidemiol 1992, 45:1431-1445.
15. Terris MK, Stamey TA: Determination of prostate volume by transrectal ultrasound. J Urol 1991, 145:984-987.
16. Barry MJ, Fowler FJ Jr., O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, Cockett ATK, Measurement..Committee.of.the.American. Urological.Association T: The American Urological Association Symptom Index for Benign Prostatic Hyperplasia. J Urol 1992, 148:1549-1557.
17. Corica FA, Jacobsen SJ, King BF, Bostwick DG, Jacobson DJ, Girman CJ, Guess HA, Lieber MM: Prostatic central zone volume, lower urinary tract symptom severity and peak urinary flow rates in community-dwelling men. Journal of Urology 1999, 161:831-834.
18. Rule AD, Larson TS, Bergstralh EJ, Slezak JM, Jacobsen SJ, Cosio FG: Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. Ann Intern Med 2004, 141:929-937.
19. Gades NM, Nehra A, Jacobson DJ, McGree ME, Girman CJ, Rhodes T, Roberts RO, Lieber MM, Jacobsen SJ: Association between smoking and erectile dysfunction: A population-based study. Am J Epidemiol 2005, 161:346-351.
20. Muller A, Mulhall JP: Cardiovascular disease, metabolic syndrome and erectile dysfunction. Curr Opin Urol 2006, 16:435-443.
21. Rockwood K, Stolee P, Robertson D, Shillington ER: Response bias in a health status survey of elderly people. Age Ageing 1989, 18:177-182.
22. Launer LJ, Wind AW, Deeg DJ: Nonresponse pattern and bias in a community-based cross-sectional study of cognitive functioning among the elderly. Am J Epidemiol 1994, 139:803-812.
23. Taylor JM, Cooper KL, Wei JT, Sarma AV, Raghunathan TE, Heeringa SG: Use of multiple imputation to correct for nonresponse bias in a survey of urologic symptoms among African-American men. Am J Epidemiol 2002, 156:774-782.
24. Dudley J, Jin S, Hoover D, Metz S, Thackeray R, Chmiel J: The Multicenter AIDS Cohort Study: retention after 9 1/2 years. Am J Epidemiol 1995, 142:323-330.
25. Cartmel B, Moon TE, Levine N, Rodney S, Alberts D: Predictors of inactivation and reasons for participant inactivation during a skin cancer chemoprevention study. Cancer Epidemiol Biomarkers Prev 2000, 9:999-1002.
26. Panser LA, Chute CG, Guess HA, LarsonKeller JJ, Girman CJ, Oesterling JE, Lieber MM, Jacobsen SJ: The natural history of prostatism: the effects of non-response bias. Int J Epidemiol 1994, 23:1198-1205.
27. Jacobsen SJ, Jacobson DJ, Girman CJ, Roberts RO, Rhodes T, Guess HA, Lieber MM: Natural history of prostatism: Risk factors for acute urinary retention. J Urol 1997, 158:481-487.